Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex

International Journal of Neuropsychopharmacology

Volumn 21, Issue 11, 2018, Pages 988-996

  Godlewska, Beata R ^a   Browning, Michael ^b   Norbury, Ray ^a   Igoumenou, Artemis ^c   Cowen, Philip J ^d   Harmer, Catherine J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ROEHAMPTON   (United Kingdom)

^d BARNET ENFIELD AND HARINGEY MENTAL HEALTH NHS TRUST   (United Kingdom)

Author keywords

anterior cingulate cortex; Depression; Functional magnetic resonance imaging; Selective serotonin reuptake inhibitors; Treatment response prediction

Indexed keywords

ESCITALOPRAM; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; FACIAL EXPRESSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAPPINESS; HUMAN; MAJOR DEPRESSION; MALE; MORNING DOSAGE; PREDICTION; PRIORITY JOURNAL; SADNESS; TREATMENT OUTCOME; TREATMENT RESPONSE; CINGULATE GYRUS; DEPRESSION; DIAGNOSTIC IMAGING; EMOTION; FACIAL RECOGNITION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PSYCHOLOGICAL RATING SCALE;

ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FACIAL EXPRESSION; FACIAL RECOGNITION; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS;

EID: 85055824193     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyy069     Document Type: Article

References (38)

1. Angst J, Delini-Stula A, Stabl M, Stassen HH (1993) Is a cutoff score a suitable measure of treatment outcome in short-Term trials in depression? A methodological meta-Analysis. Hum Psychopharmacol 8:311-317.
2. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, Bullmore E (2007) Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 62:407-414.
3. Crane NA, Jenkins LM, Bhaumik R, Dion C, Gowins JR, Mickey BJ, Zubieta JK, Langenecker SA (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486.
4. Cullen KR, Klimes-Dougan B, Vu DP, Westlund Schreiner M, Mueller BA, Eberly LE, Camchong J, Westervelt A, Lim KO (2016) Neural correlates of antidepressant treatment response in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 26:705-712.
5. Davidson RJ, Irwin W, Anderle MJ, Kalin NH (2003) The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160:64-75.
6. Dichter GS, Gibbs D, Smoski MJ (2015) A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. J Affect Disord 172:8-17.
7. Drevets WC (2001) Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11:240-249.
8. Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS (2017) Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitivebehavioral therapy or antidepressant medication for major depressive disorder. Am J Psychiatry 174:533-545.
9. Fettes P, Schulze L, Downar J (2017) Cortico-striatal-Thalamic loop circuits of the orbitofrontal cortex: promising therapeutic targets in psychiatric illness. Front Syst Neurosci 11:25.
10. Fu CH, Costafreda SG (2013) Neuroimaging-based biomarkers in psychiatry: clinical opportunities of a paradigm shift. Can J Psychiatry 58:499-508.
11. Fu CH, Steiner H, Costafreda SG (2013) Predictive neural biomarkers of clinical response in depression: A meta-Analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis 52:75-83.
12. Godlewska BR, Browning M, Norbury R, Cowen PJ, Harmer CJ (2016) Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Transl Psychiatry 6:e957.
13. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
14. Hastie T, Tibshirani R, Friedman J. Model Assessment and Selection (2009) In: The Elements of Statistical Learning. Spinger-Verlag, 219-260.
15. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) FSL. Neuroimage 62:782-790.
16. Kennedy SH, Evans KR, Kröger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ (2001) Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 158:899-905.
17. Klumpp H, Fitzgerald JM, Kinney KL, Kennedy AE, Shankman SA, Langenecker SA, Phan KL (2017) Predicting cognitive behavioral therapy response in social anxiety disorder with anterior cingulate cortex and amygdala during emotion regulation. Neuroimage Clin 15:25-34.
18. Kozel FA, Rao U, Lu H, Nakonezny PA, Grannemann B, McGregor T, Croarkin PE, Mapes KS, Tamminga CA, Trivedi MH (2011) Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Front Psychiatry 2:7.
19. Maia TV, Frank MJ (2011) From reinforcement learning models to psychiatric and neurological disorders. Nat Neurosci 14:154-162.
20. Mayberg HS (2003) Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65:193-207.
21. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT (1997) Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8:1057-1061.
22. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA (2000) Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48:830-843.
23. McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR, Craddock RC, Mayberg HS (2013) Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 70:821-829.
24. Miller JM, Schneck N, Siegle GJ, Chen Y, Ogden RT, Kikuchi T, Oquendo MA, Mann JJ, Parsey RV (2013) FMRI response to negative words and SSRI treatment outcome in major depressive disorder: A preliminary study. Psychiatry Res 214: 296-305.
25. National Institute for Health and Care Excellence (2017) NICE pathways. Antidepressant treatment in adults.
26. Pizzagalli DA (2011) Frontocingulate dysfunction in depression: Toward biomarkers of treatment response. Neuropsychopharmacology 36:183-206.
27. Price JL, Drevets WC (2010) Neurocircuitry of mood disorders. Neuropsychopharmacology 35:192-216.
28. Roy M, Harvey PO, Berlim MT, Mamdani F, Beaulieu MM, Turecki G, Lepage M (2010) Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression. J Psychiatry Neurosci 35:152-162.
29. Rush AJ, Warden D, Wisniewski SR, Fava M, Trivedi MH, Gaynes BN, Nierenberg AA (2009) STARD: revising conventional wisdom. CNS Drugs 23:627-647.
30. Spielberger CD (1989) State-Trait anxiety inventory bibliography. 2nd ed. Palo Alto, CA: Consulting Psychologists Press.
31. Spitzer RL, Williams JBW, Gibbon M, First MB (1995) Structured clinical interview for DSM-1 V (SCID) biometrics research. New York: New York State Psychiatric Institute.
32. Stevens FL, Hurley RA, Taber KH (2011) Anterior cingulate cortex: unique role in cognition and emotion. J Neuropsychiatry Clin Neurosci 23:121-125.
33. Vai B, Bulgarelli C, Godlewska BR, Cowen PJ, Benedetti F, Harmer CJ (2016) Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration. Eur Neuropsychopharmacol 26:2000-2010.
34. Victor TA, Furey ML, Fromm SJ, Ohman A, Drevets WC (2010) Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch Gen Psychiatry 67:1128-1138.
35. Victor TA, Furey ML, Fromm SJ, Öhman A, Drevets WC (2013) Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder. Int J Neuropsychopharmacol 16:2195-2208.
36. Victor TA, Drevets WC, Misaki M, Bodurka J, Savitz J (2017) Sex differences in neural responses to subliminal sad and happy faces in healthy individuals: implications for depression. J Neurosci Res 95:703-710.
37. Vogt BA (2016) Midcingulate cortex: structure, connections, homologies, functions and diseases. J Chem Neuroanat 74:28-46.
38. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR (2007) The STARD project results: A comprehensive review of findings. Curr Psychiatry Rep 9:449-459.